
Webinar | Fragment-Based Drug Discovery (FBDD) Application
Efficiently Driving Protein-based NMR Fragment Screening and Lead Discovery Dr. Andrew “Dru” Namanja, Principal Research…
Efficiently Driving Protein-based NMR Fragment Screening and Lead Discovery Dr. Andrew “Dru” Namanja, Principal Research…
Advanced NMR Strategies for Pharmaceutical Molecule Characterization and Structure Analysis Dr. María Victoria Silva Elipe,…
Join us for a webinar on “CASE (Computer-Assisted Structure Elucidation) Studies for Benchtop NMR system”…
Liquid-state NMR plays a pivotal role in resolving the structural mysteries of molecular compounds across diverse fields such as synthetic organic and inorganic chemistry, as well as medicinal chemistry
Fragment-Based Drug Discovery (FBDD) and validation of small molecules binders using NMR has emerged as a powerful method in early-stage drug development…
Mnova 15 is a major release that incorporates many new features in NMR, MSChrom, Mgears,…
Mnova 15 is a game-changing release, introducing new products, versions, and commercial adjustments. Enhancements across plugins like NMR, MSChrom, Chemometrics, and DB deliver an upgraded user experience.
We are excited to announce that Chrom Reaction Optimization is close to release, and we couldn’t be more eager to share a sneak peek with you! Revamped interface, improved methods, more customization, …
The screening and selection of the best chromatographic methods play a pivotal role in the synthetic chemistry pipeline as it allows the obtention of high-purity materials for downstream uses.
In this application note, our colleague Gary Sharman explains how Mnova’s automated solution enables scientists to save valuable time in their reaction optimization processes to swiftly proceed to other tasks and maximize productivity.